Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EW0162 / 1||- / IM|
Administered by: Private Purchased by: ??
Symptoms: COVID-19, SARS-CoV-2 test positive, Asymptomatic COVID-19
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: acyclovir, albuterol nebs, diclofenac, fluticasone-salmeterol, gabapentin, hydroxyzine, montelukast, trazodone
Preexisting Conditions: Vitamin D deficiency, seasonal affective disorder, reflux, radiculopathy - lumbosacral region, pes planus, obesity, neck pain, multiple allergies, herniated lumbar intervertebral disc, GERD, dysphagia, depression, COPD, chronic pain, ADD, asthma, arthritis, anxiety, allergic rhinitis, alcohol abuse, sleep difficulties, hypertension, hypertriglyceridemia, oral herpes simplex, benign neoplasm of breast, cervical spinal stenosis.
Allergies: aspirin, naproxen, jalapenos, gluten meal, salicylates, zofran.
Diagnostic Lab Data:
CDC 'Split Type':
Write-up: Pt completed vaccination series for the COVID-19 Pfizer, with one dose received 4/6/2021 and the 2nd received 4/27/2021. Pt was seen at ED on 6/26/2021 for mental health related reasons, and tested positive for COVID-19 as part of routine admission screening. Medical notes indicate the patient was asymptomatic for COVID-19.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166